A luminescent biosensor for ex vivo detection of HER2-positive breast cancer based on a novel affiprobe-Reference-Cited by-同舟云学术

A luminescent biosensor for ex vivo detection of HER2-positive breast cancer based on a novel affiprobe

Published:2019 Issue:33 Volume:11 Page:4233-4241
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Nazari Mahboobeh¹²³⁴⁵^ORCID,Emamzadeh Rahman⁶⁷⁸⁹⁵^ORCID,Minai-Tehrani Arash¹⁰²³⁴⁵,Nasir shirazi Mohadeseh¹²³⁴⁵,Naimi Azar¹¹¹²¹³⁹⁵

Affiliation:

1. Monoclonal Antibody Research Center

2. Avicenna Research Institute

3. ACECR

4. Tehran

5. Iran

6. Department of Biology

7. Faculty of Sciences

8. University of Isfahan

9. Isfahan

10. Nanobiotechnology Research Center

11. Department of Pathology

12. School of Medicine

13. Isfahan University of Medical Sciences

Abstract

A novel receptor tyrosine-protein kinase erbB-2 (HER2)-binding affiprobe – named Z_HER2:342-RLuc – was designed, produced and assessed in terms of function to detect HER2 positive cells and for preliminary clinical diagnosis.

Funder

Iran National Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/AY/C9AY01077G

Reference49 articles.

1. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

2. American College of Radiology , Breast Imaging Reporting and Data System (BI-RADS®) , American College of Radiology , Reston, VA , 4th edn, 2003

3. HER2/neu role in breast cancer: from a prognostic foe to a predictive friend

4. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

5. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel NanoMIP–SPR Sensor for the Point-of-Care Diagnosis of Breast Cancer;Micromachines;2023-05-21

2. A recombinant affitoxin derived from a HER3 affibody and diphteria-toxin has potent and selective antitumor activity;International Journal of Biological Macromolecules;2022-10